Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Rinaldi

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
JCI Insight|July 8, 2024
Protein biomarker signature in patients with spinal and bulbar muscular atrophyAndrew Tn Tebbenkamp, Spencer B Huggett, Vittoria Lombardi, et al.
Journal of Neurology|March 3, 2005
The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathyValentina Scarano, Pietro Mancini, Chiara Criscuolo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 13, 2016
MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular AtrophyNaemeh Pourshafie, Philip R Lee, Ke-Lian Chen, et al.
Molecular Psychiatry|January 17, 2020
MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moietiesNipun Chopra, Ruizhi Wang, Bryan Maloney, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 3, 2019
Plasma pNfH levels differentiate SBMA from ALSVittoria Lombardi, Alessandro Bombaci, Luca Zampedri, et al.
Neurobiology of Disease|June 14, 2014
Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patientsChristopher Grunseich, Kristen Zukosky, Ilona R Kats, et al.
Nanoscale Advances|June 1, 2023
A modular RNA delivery system comprising spherical nucleic acids built on endosome-escaping polymeric nanoparticlesAntonio Garcia-Guerra, Ruth Ellerington, Jens Gaitzsch, et al.
Journal of Huntington'S Disease|July 27, 2014
Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington's disease patientsCinzia V Russo, Elena Salvatore, Francesco Saccà, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapyRoberta Lanzillo, Giuseppe Orefice, Mario Quarantelli, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 6, 2012
Predictors of survival in a Huntington's disease population from southern ItalyCarlo Rinaldi, Elena Salvatore, Ilaria Giordano, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
JCI Insight|July 8, 2024
Protein biomarker signature in patients with spinal and bulbar muscular atrophyAndrew Tn Tebbenkamp, Spencer B Huggett, Vittoria Lombardi, et al.
Journal of Neurology|March 3, 2005
The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathyValentina Scarano, Pietro Mancini, Chiara Criscuolo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 13, 2016
MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular AtrophyNaemeh Pourshafie, Philip R Lee, Ke-Lian Chen, et al.
Molecular Psychiatry|January 17, 2020
MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moietiesNipun Chopra, Ruizhi Wang, Bryan Maloney, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 3, 2019
Plasma pNfH levels differentiate SBMA from ALSVittoria Lombardi, Alessandro Bombaci, Luca Zampedri, et al.
Neurobiology of Disease|June 14, 2014
Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patientsChristopher Grunseich, Kristen Zukosky, Ilona R Kats, et al.
Nanoscale Advances|June 1, 2023
A modular RNA delivery system comprising spherical nucleic acids built on endosome-escaping polymeric nanoparticlesAntonio Garcia-Guerra, Ruth Ellerington, Jens Gaitzsch, et al.
Journal of Huntington'S Disease|July 27, 2014
Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington's disease patientsCinzia V Russo, Elena Salvatore, Francesco Saccà, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapyRoberta Lanzillo, Giuseppe Orefice, Mario Quarantelli, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 6, 2012
Predictors of survival in a Huntington's disease population from southern ItalyCarlo Rinaldi, Elena Salvatore, Ilaria Giordano, et al.
Pageof 7